Amplify CWP Enhanced Dividend Income ETF (DIVO) has gained 6.6% year-to-date but lags the S&P 500 due to high 10-year Treasury yields near 4.62%, which limit dividend stock valuations. The ETF combines blue-chip dividend growers like Johnson & Johnson and Procter & Gamble with a covered-call strategy that depends on market volatility. Currently, the VIX volatility index is low, reducing call premium income that boosts DIVO's payouts. Investors should watch Treasury yields and VIX levels, as a drop in yields below 4.3% or a rise in volatility above 20 could improve DIVO's valuation and income potential.
The iShares Core Dividend Growth ETF (DGRO) is facing challenges as the 10-year Treasury yield approaches its 12-month high. This makes DGRO's dividend growth less attractive compared to risk-free Treasury notes. Investors should monitor the 10-year ...
Vanguard High Dividend Yield ETF (VYM) manages $94.6 billion in assets, focusing on large-cap U.S. stocks with high dividend yields. Its top holdings, including Johnson & Johnson and Procter & Gamble, have strong dividend coverage and consistent payo...
The NEOS S&P 500 High Income ETF (SPYI) has returned 8% year-to-date and 19% over the past year, driven mainly by its 12% annualized distribution from selling call options on S&P 500 stocks. However, with market volatility (VIX) decreasing below its ...
Johnson & Johnson reported strong Q2 earnings, driven by a 41.1% year-on-year sales increase of its depression treatment Spravato, reaching $584 million. The company raised its 2026 adjusted diluted EPS guidance from $11.45-$11.65 to $11.6-$11.75, re...
Johnson & Johnson reported strong Q2 sales of $584 million for Spravato, a nasal spray for treatment-resistant depression, signaling robust market potential for psychedelic drugs. Jefferies highlights this growth supports the commercial viability of ...
